HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Redl Selected Research

Fibrin Tissue Adhesive (Fibrin Sealant)

8/2015Erratum to: The impact of hydrophobic hernia mesh coating by omega fatty acid on atraumatic fibrin sealant fixation.
8/2015The impact of hydrophobic hernia mesh coating by omega fatty acid on atraumatic fibrin sealant fixation.
1/2012The impact of atraumatic fibrin sealant vs. staple mesh fixation in TAPP hernia repair on chronic pain and quality of life: results of a randomized controlled study.
10/2011Biologic hernia implants in experimental intraperitoneal onlay mesh plasty repair: the impact of proprietary collagen processing methods and fibrin sealant application on tissue integration.
12/2010A comparison of a bovine albumin/glutaraldehyde glue versus fibrin sealant for hernia mesh fixation in experimental onlay and IPOM repair in rats.
10/2008The assessment of quality of life in a trial on lightweight mesh fixation with fibrin sealant in transabdominal preperitoneal hernia repair.
2/2003Delivery of high dose VEGF plasmid using fibrin carrier does not influence its angiogenic potency.
12/2000Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Redl Research Topics

Disease

8Hernia (Hernias)
01/2017 - 12/2005
5Wounds and Injuries (Trauma)
01/2012 - 11/2000
4Sepsis (Septicemia)
06/2014 - 11/2000
4Chronic Pain
01/2012 - 10/2007
4Ischemia
02/2003 - 05/2001
3Hemorrhage
01/2013 - 11/2000
3Shock
11/2000 - 01/2000
2Cicatrix (Scar)
01/2017 - 12/2009
2Inflammation (Inflammations)
10/2011 - 10/2007
2Ventral Hernia
10/2010 - 12/2005
2Spinal Cord Injuries (Spinal Cord Injury)
07/2006 - 12/2000
2Seizures (Absence Seizure)
01/2002 - 12/2000
1Infections
01/2018
1Abdominal Hernia (Abdominal Hernias)
01/2018
1Thrombosis (Thrombus)
05/2013
1Inguinal Hernia (Direct Inguinal Hernia)
01/2012
1Foreign-Body Reaction
10/2011
1Stress Fractures (Stress Fracture)
04/2011
1Vascular System Injuries
12/2008
1Pain (Aches)
10/2008
1Ischemic Stroke
07/2006
1Spinal Cord Compression
07/2006
1Hypothermia
05/2002
1Acute Subdural Hematoma
05/2002
1Craniocerebral Trauma (Head Injury)
05/2002
1Hyperventilation
05/2002
1Disseminated Intravascular Coagulation
12/2001
1Pulmonary Hypertension
08/2001
1Acute Lung Injury
08/2001
1Lung Injury
08/2001
1Hypotension (Low Blood Pressure)
08/2001
1Hypoxia (Hypoxemia)
08/2001
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2001
1Hemorrhagic Shock
01/2001
1Spasm (Spasms)
12/2000
1Respiratory Insufficiency (Respiratory Failure)
12/2000
1Traumatic Shock
11/2000

Drug/Important Bio-Agent (IBA)

8Fibrin Tissue Adhesive (Fibrin Sealant)IBA
08/2015 - 12/2000
3CollagenIBA
01/2017 - 10/2010
3FibrinIBA
10/2008 - 01/2002
3EndotoxinsIBA
08/2001 - 11/2000
2Biological ProductsIBA
01/2017 - 10/2011
2Fatty Acids (Saturated Fatty Acids)IBA
08/2015 - 08/2015
2tetra-4-amidinophenoxypropane (TAPP)IBA
01/2012 - 10/2008
2Protein CIBA
07/2006 - 12/2000
2Tranexamic Acid (AMCA)FDA Link
01/2002 - 12/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2001 - 05/2001
2ProcalcitoninIBA
07/2001 - 11/2000
2Arginine (L-Arginine)FDA Link
05/2001 - 05/2000
2Nitric Oxide Synthase (NO Synthase)IBA
05/2001 - 05/2000
2CytokinesIBA
01/2001 - 11/2000
2NitritesIBA
05/2000 - 01/2000
1Biocompatible Materials (Biomaterials)IBA
01/2018
1SolutionsIBA
01/2018
1Plasminogen Activator Inhibitor 1IBA
06/2014
1Plasminogen InactivatorsIBA
06/2014
1Hemostatics (Antihemorrhagics)IBA
01/2013
1surgisisIBA
10/2011
1Bovine Serum AlbuminIBA
12/2010
1Glutaral (Glutaraldehyde)IBA
12/2010
1Polypropylenes (Polypropylene)IBA
10/2010
1PolymersIBA
10/2010
1PolyestersIBA
10/2010
14- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA
06/2010
1Complementary DNA (cDNA)IBA
06/2010
1Proteins (Proteins, Gene)FDA Link
06/2010
1Messenger RNA (mRNA)IBA
06/2010
1Peptide Hydrolases (Proteases)FDA Link
12/2009
1glubranIBA
10/2007
1drotrecogin alfa activated (Xigris)FDA Link
07/2006
1Neuroprotective AgentsIBA
07/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2003
1Mannitol (Osmitrol)FDA LinkGeneric
05/2002
1Dacarbazine (DIC)FDA LinkGeneric
12/2001
1salicylhydroxamic acid (SHAM)IBA
10/2001
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2001
1ChemokinesIBA
07/2001
1nitrosyl hemoglobin (Hb X)IBA
05/2001
1C-Reactive ProteinIBA
11/2000
1Gentamicins (Gentamicin)FDA LinkGeneric
11/2000
1Anti-Bacterial Agents (Antibiotics)IBA
11/2000
1NeopterinIBA
11/2000
1Interleukin-6 (Interleukin 6)IBA
11/2000

Therapy/Procedure

4Therapeutics
02/2015 - 11/2000
4Herniorrhaphy
01/2012 - 10/2007
1Transcutaneous Electric Nerve Stimulation (TENS)
01/2018
1Ligation
06/2014
1Punctures
06/2014
1Microspheres (Microsphere)
05/2013
1Vascular Surgical Procedures
01/2013
1Sutures (Suture)
01/2012
1Transplantation
04/2011
1Operative Surgical Procedures
12/2008
1Craniotomy
05/2002
1Trephining
05/2002
1Myocutaneous Flap
10/2001
1Lasers (Laser)
10/2001
1Continuous Renal Replacement Therapy
08/2001
1Resuscitation
01/2001
1Suture Techniques
01/2001